Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InsiderCline Christopher R.
This page shows the track record and history of Cline Christopher R. insider trades in Travere Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Cline Christopher R. in TVTX / Travere Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TVTX / Travere Therapeutics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Cline Christopher R. in TVTX / Travere Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-09-03 454 18.2000 454 18.2000 8,263 0 19.6100 641 7.76
2025-05-05 1,784 21.0500 1,784 21.0500 37,553
2025-04-11 48 13.1446 48 13.1446 631
2025-02-03 5,192 20.1200 5,192 20.1200 104,463
2025-01-22 865 18.9409 865 18.9409 16,384
2024-09-09 2,490 11.5200 2,490 11.5200 28,685
2024-09-04 514 9.5093 514 9.5093 4,888
2024-04-11 54 6.7400 54 6.7400 364
2024-02-01 3,818 8.5313 3,818 8.5313 32,573
2024-01-23 853 9.0684 853 9.0684 7,735
2023-09-05 457 14.7102 457 14.7102 6,723
2023-05-10 455 16.5900 455 16.5900 7,548
2023-04-11 47 21.4900 47 21.4900 1,010
2023-02-01 1,588 21.7520 1,588 21.7520 34,542
2023-01-24 852 21.9044 852 21.9044 18,663

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TVTX / Travere Therapeutics, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-05 2025-09-04 4 Cline Christopher R. TVTX Common Stock S - Sale D 19.7100 -119 -2 92,083
2025-09-05 2025-09-03 4 Cline Christopher R. TVTX Common Stock S - Sale D 18.2000 -454 -8 92,202
2025-08-28 2025-08-27 4 Cline Christopher R. TVTX Common Stock S - Sale D 17.3100 -470 -8 92,656
2025-05-05 2025-05-05 4 Cline Christopher R. TVTX Common Stock S - Sale D 21.0500 -1,784 -38 93,126
2025-05-05 2025-05-02 4 Cline Christopher R. TVTX Common Stock M - Exercise D 4,920 94,910
2025-04-14 2025-04-11 4 Cline Christopher R. TVTX Common Stock S - Sale D 13.1446 -48 -1 89,990
2025-02-04 2025-02-03 4 Cline Christopher R. TVTX Common Stock S - Sale D 20.1200 -5,192 -104 90,038
2025-02-04 2025-01-31 4 Cline Christopher R. TVTX Common Stock A - Award D 21,500 95,230
2025-01-23 2025-01-22 4 Cline Christopher R. TVTX Common Stock S - Sale D 18.9409 -865 -16 73,730
2024-09-09 2024-09-09 4 Cline Christopher R. TVTX Common Stock S - Sale D 11.5200 -2,490 -29 74,595
2024-09-09 2024-09-05 4 Cline Christopher R. TVTX Common Stock A - Award D 6,750 77,085
2024-09-05 2024-09-04 4 Cline Christopher R. TVTX Common Stock S - Sale D 9.5093 -514 -5 70,335
2024-04-12 2024-04-11 4 Cline Christopher R. TVTX Common Stock S - Sale D 6.7400 -54 -0 70,849
2024-02-02 2024-02-01 4 Cline Christopher R. TVTX Common Stock S - Sale D 8.5313 -3,818 -33 70,903
2024-02-02 2024-01-31 4 Cline Christopher R. TVTX Common Stock A - Award D 25,000 74,721
2024-01-25 2024-01-23 4 Cline Christopher R. TVTX Common Stock S - Sale D 9.0684 -853 -8 49,721
2023-09-05 2023-09-05 4 Cline Christopher R. TVTX Common Stock S - Sale D 14.7102 -457 -7 50,574
2023-05-12 2023-05-10 4 Cline Christopher R. TVTX Common Stock S - Sale D 16.5900 -455 -8 51,031
2023-04-13 2023-04-11 4 Cline Christopher R. TVTX Common Stock S - Sale D 21.4900 -47 -1 51,486
2023-02-02 2023-02-01 4 Cline Christopher R. TVTX Common Stock S - Sale D 21.7520 -1,588 -35 51,533
2023-02-02 2023-01-31 4 Cline Christopher R. TVTX Common Stock A - Award D 20,250 53,121
2023-01-26 2023-01-24 4 Cline Christopher R. TVTX Common Stock S - Sale D 21.9044 -852 -19 32,871
2022-09-01 3 Cline Christopher R. TVTX Common Stock D 28,723
2022-09-01 2022-09-01 4 Cline Christopher R. TVTX Common Stock A - Award D 5,000 33,723
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)